Inventor
Rosanne M. Crooke
Inventor
Carlsbad, CA, US
Overview
Patents· 50 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C12Nprimary
C12NMicroorganisms or enzymes28%
A61KPreparations for medical, dental or toiletry purposes25%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations24%
Y02PClimate change mitigation technologies in the production or processing of goods10%
C07HSugars6%
C12YEnzymes2%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms2%
G01NInvestigating or analysing materials by determining their chemical or physical properties1%
A01KAnimal husbandry1%
PatentTitleYear
11,118,183Modulation of angiopoietin-like 3 expression202110,875,884Compositions and methods for modulating angiopoietin-like 3 expression202010,858,657Methods for treating hypercholesterolemia202010,478,448Methods and compositions for modulating apolipoprotein (a) expression201910,472,629Methods and compositions for modlating apolipoprotein (A) expression20199,957,292Compositions and methods for modulating angiopoietin-like 3 expression20189,909,124'Compounds and methods for modulating apolipoprotein C-III expression for improving a diabetic profile'20189,885,045'Methods and compositions for modulating apolipoprotein (a) expression'20189,884,072'Methods and compositions for modulating apolipoprotein (a) expression'20189,650,636'Methods for treating hypercholesterolemia'20179,624,496'Modulation of apolipoprotein C-III expression'20179,574,193'Methods and compositions for modulating apolipoprotein (a) expression'20179,382,540'Compositions and methods for modulating angiopoietin-like 3 expression'20169,365,848'Modulation of apolipoprotein C-III expression'20169,157,082'Modulation of apolipoprotein CIII (ApoCIII) expression'20159,139,831'Modulation of angiopoietin-like 3 expression'20158,916,694'SNPs of apolipoprotein B and modulation of their expression'20148,912,160'Methods for treating hypercholesterolemia'20148,859,514'Modulation of C-reactive protein expression'20148,735,364'Antisense modulation of apolipoprotein B expression'20148,710,023'Antisense modulation of C-reactive protein expression'20148,673,632'Modulation of apolipoprotein (a) expression'20148,664,190'Methods for treating hypercholesterolemia'20148,653,047'Modulation of angiopoietin-like 3 expression'2014RE044760'Antisense modulation of apolipoprotein B-expression'20148,530,439'Modulation of apolipoprotein C-III expression'20138,492,355'Antisense modulation of apolipoprotein B expression'20138,138,328'Modulation of apolipoprotein (A) expression'20128,093,224'Antisense modulation of C-reactive protein expression'20128,093,222'Methods for treating hypercholesterolemia'20128,084,437'Methods for treating hypercholesterolemia'20117,915,231'Antisense modulation of C-reactive protein expression'20117,888,324'Antisense modulation of apolipoprotein B expression'20117,863,252'Modulation of C-reactive protein expression'20117,803,930'Antisense modulation of apolipoprotein B-expression'20107,750,141'Modulation of apolipoprotein c-III expression'20107,741,305'Modulation of apolipoprotein (a) expression'20107,723,508'Modulation of apolipoprotein (A) expression'20107,598,227'Modulation of apolipoprotein C-III expression'20097,491,815'Antisense modulation of C-reactive protein expression'20097,425,545'Modulation of C-reactive protein expression'20087,407,943'Antisense modulation of apolipoprotein B expression'20087,335,764'Antisense modulation of acyl CoA cholesterol acyltransferase-2 expression'20087,326,693'Antisense modulation of c-reactive protein expression'20087,259,150'Modulation of apolipoprotein (a) expression'20077,227,014'Antisense modulation of apolipoprotein (a) expression'20077,202,357'Antisense modulation of acyl CoA cholesterol acyltransferase-2 expression'20077,132,529'Antisense modulation of stearoyl-CoA desaturase expression'20066,964,950'Antisense modulation of C-reactive protein expression'20056,767,739'Antisense modulation of microsomal triglyceride transfer protein expression'2004Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2004–2020Patents assigned to ISIS PHARMACEUTICALS INC (35)· patent assignee history
2004–2021Based in Carlsbad, CA, US· patent location history
2011–2015Patents assigned to CROOKE ROSANNE M (13)· patent assignee history
2011–2015Patents assigned to GRAHAM MARK J (13)· patent assignee history
2011–2014Patents assigned to GENZYME CORP (4)· patent assignee history
2016–2021Patents assigned to IONIS PHARMACEUTICALS INC (13)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ISIS PHARMACEUTICALS INC | 35 | 2004–2020 |
| CROOKE ROSANNE Mself | 13 | 2011–2015 |
| GRAHAM MARK J | 13 | 2011–2015 |
| IONIS PHARMACEUTICALS INC | 13 | 2016–2021 |
| GENZYME CORP | 4 | 2011–2014 |
Locations
| Location | Patents | Span |
|---|---|---|
| Carlsbad, California, US | 50 | 2004–2021 |